Fluorouracil News and Research

RSS
Fluorouracil is a drug used to treat symptoms of cancer of the colon, breast, stomach, and pancreas. It is also used in a cream to treat certain skin conditions. Fluorouracil stops cells from making DNA and it may kill cancer cells. It is a type of antimetabolite. Also called 5-fluorouracil and 5-FU.
Stage IV colorectal cancer: Therapy that improves overall survival over IFL/bevacizumab will earn 60% patient share

Stage IV colorectal cancer: Therapy that improves overall survival over IFL/bevacizumab will earn 60% patient share

Latest treatment options for colorectal cancer highlighted at NCCN Annual Conference

Latest treatment options for colorectal cancer highlighted at NCCN Annual Conference

Obesity linked to increased risk of cancer recurrence and death

Obesity linked to increased risk of cancer recurrence and death

FDA approves Taro Pharmaceutical Industries' Fluorouracil Topical Cream ANDA

FDA approves Taro Pharmaceutical Industries' Fluorouracil Topical Cream ANDA

Poniard Pharmaceuticals reports net loss of $13.2M for fourth-quarter 2009

Poniard Pharmaceuticals reports net loss of $13.2M for fourth-quarter 2009

Histone modifications associated with pancreatic cancer development and progression

Histone modifications associated with pancreatic cancer development and progression

Research study on epigenetic phenotypes published online in the Journal of Clinical Oncology

Research study on epigenetic phenotypes published online in the Journal of Clinical Oncology

Keryx Biopharmaceuticals reaches agreement with FDA on SPA for Phase 3 trial of KRX-0401

Keryx Biopharmaceuticals reaches agreement with FDA on SPA for Phase 3 trial of KRX-0401

Final data from Poniard Pharmaceuticals' randomized Phase 2 trial of picoplatin announced

Final data from Poniard Pharmaceuticals' randomized Phase 2 trial of picoplatin announced

Four commonly used chemotherapy drugs disrupt birth of new brain cells, shows study

Four commonly used chemotherapy drugs disrupt birth of new brain cells, shows study

Chemotherapy improves overall survival in postmenopausal breast cancer patients

Chemotherapy improves overall survival in postmenopausal breast cancer patients

Librax AG version launched by Oceanside Pharmaceuticals

Librax AG version launched by Oceanside Pharmaceuticals

FISH technology accurate in measuring the HER-2 receptor in human breast tumors

FISH technology accurate in measuring the HER-2 receptor in human breast tumors

Updated clinical data from Poniard Pharmaceuticals' picoplatin Phase 2 trial announced

Updated clinical data from Poniard Pharmaceuticals' picoplatin Phase 2 trial announced

Capecitabine in chemotherapy regimen reduces early breast cancer recurrence

Capecitabine in chemotherapy regimen reduces early breast cancer recurrence

Poniard Pharmaceuticals to present picoplatin Phase 2 trial data at the AACR-NCI -EORTC conference

Poniard Pharmaceuticals to present picoplatin Phase 2 trial data at the AACR-NCI -EORTC conference

NCCN Guidelines for breast cancer does not recommend prophylactic mastectomy in women

NCCN Guidelines for breast cancer does not recommend prophylactic mastectomy in women

Clinical trial helps improve prognosis and changes the standard of care for patients with colorectal cancer

Clinical trial helps improve prognosis and changes the standard of care for patients with colorectal cancer

Promising results from Cell Therapeutics' phase II OPAXIO study for advanced esophageal cancer

Promising results from Cell Therapeutics' phase II OPAXIO study for advanced esophageal cancer

Bristol-Myers announces availability of ERBITUX for metastatic colorectal cancer treatment

Bristol-Myers announces availability of ERBITUX for metastatic colorectal cancer treatment